Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy (DIABELOOP SP8) (DIABELOOP SP8)
Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy in a Randomized Trial for 3 Months Followed by an Extension Period
Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Terminated
Covid-19
Other terminated trials from Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
This NA trial investigates Closed-Loop and Diabetes Mellitus, Type 1 and is currently terminated or withdrawn. Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2021 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Sep 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Jan 2020 — Apr 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
For direct contact, visit the study record on ClinicalTrials.gov .